ROFLUMILAST

ROFLUMILAST was reported 7259 times

ROFLUMILAST is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PLETHYSMOGRAPHY 17 0.6538
1 MICROSTOMIA 5 0.1042
2 LUNG DIFFUSION DISORDER 11 0.0701
3 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 26 0.0497
4 RESPIRATORY GAS EXCHANGE DISORDER 17 0.0458
5 BRONCHIAL WALL THICKENING 30 0.0417
6 BACTERIAL DISEASE CARRIER 28 0.0384
7 GAS POISONING 3 0.0370
8 ACTION TREMOR 5 0.0309
9 PNEUMOTHORAX SPONTANEOUS 20 0.0295
10 MYCOBACTERIUM TEST POSITIVE 6 0.0291
11 FORCED EXPIRATORY VOLUME ABNORMAL 4 0.0276
12 BRONCHIAL SECRETION RETENTION 30 0.0235
13 SPIROMETRY ABNORMAL 13 0.0217
14 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 670 0.0128
15 DEVICE ALLERGY 3 0.0120
16 OXYGEN SATURATION INCREASED 4 0.0118
17 INSPIRATORY CAPACITY DECREASED 3 0.0108
18 NAIL DYSTROPHY 6 0.0107
19 ASBESTOSIS 3 0.0106
20 OXYGEN CONSUMPTION DECREASED 6 0.0099
21 FULL BLOOD COUNT ABNORMAL 101 0.0095
22 SPUTUM DISCOLOURED 88 0.0093
23 OBSTRUCTIVE AIRWAYS DISORDER 103 0.0093
24 MITE ALLERGY 6 0.0092
25 VITAL CAPACITY DECREASED 4 0.0089
26 EMPHYSEMA 89 0.0088
27 TOTAL LUNG CAPACITY DECREASED 14 0.0088
28 ADENOCARCINOMA 19 0.0085
29 ANAESTHESIA 3 0.0082
30 DEPENDENCE ON OXYGEN THERAPY 4 0.0081
31 LUNG CARCINOMA CELL TYPE UNSPECIFIED RECURRENT 5 0.0081
32 HYPERCAPNIA 24 0.0080
33 SPUTUM INCREASED 17 0.0079
34 FORCED VITAL CAPACITY DECREASED 5 0.0077
35 CHRONIC RESPIRATORY FAILURE 9 0.0075
36 BLOOD IMMUNOGLOBULIN E INCREASED 18 0.0074
37 SPUTUM CULTURE POSITIVE 6 0.0074
38 SPINAL CORD COMPRESSION 28 0.0072
39 GASTRODUODENAL ULCER 3 0.0071
40 LUNG HYPERINFLATION 6 0.0070
41 POUCHITIS 6 0.0070
42 RIGHT VENTRICULAR DILATATION 4 0.0069
43 SYSTEMIC SCLERODERMA 5 0.0069
44 MYCOBACTERIUM AVIUM COMPLEX INFECTION 18 0.0067
45 BREATH SOUNDS ABNORMAL 33 0.0067
46 MONOCYTOSIS 4 0.0064
47 NASAL OBSTRUCTION 12 0.0064
48 OBSTRUCTIVE SLEEP APNOEA SYNDROME 9 0.0062
49 FORCED EXPIRATORY VOLUME DECREASED 17 0.0060
50 POLYMYALGIA RHEUMATICA 19 0.0060
51 BRONCHIECTASIS 40 0.0059
52 PNEUMONIA PSEUDOMONAL 9 0.0059
53 OXYGEN CONSUMPTION INCREASED 14 0.0059
54 COATING IN MOUTH 3 0.0056
55 RALES 32 0.0055
56 OXYGEN THERAPY 9 0.0055
57 OXYGEN SUPPLEMENTATION 4 0.0054
58 EXPOSURE TO COMMUNICABLE DISEASE 4 0.0053
59 INTENTIONAL DEVICE MISUSE 23 0.0052
60 TELANGIECTASIA 5 0.0052
61 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 86 0.0051
62 MULTIPLE ALLERGIES 39 0.0050
63 GASTROINTESTINAL POLYP HAEMORRHAGE 3 0.0050
64 ARTHROPOD STING 8 0.0048
65 PULMONARY FUNCTION TEST DECREASED 21 0.0048
66 INHALATION THERAPY 3 0.0048
67 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 5 0.0047
68 INCREASED VISCOSITY OF BRONCHIAL SECRETION 3 0.0047
69 ACTIVITIES OF DAILY LIVING DECREASED 3 0.0047
70 INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE 3 0.0047
71 PULMONARY MASS 69 0.0046
72 RIGHT VENTRICULAR DYSFUNCTION 5 0.0045
73 PULMONARY FUNCTION TEST ABNORMAL 7 0.0045
74 INFUSION SITE URTICARIA 3 0.0045
75 ESSENTIAL HYPERTENSION 8 0.0044
76 SINUS PAIN 10 0.0043
77 SYSTEMIC INFECTION 7 0.0042
78 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 11 0.0041
79 INFUSION SITE DISCHARGE 7 0.0040
80 WHEEZING 230 0.0039
81 DYSPNOEA AT REST 11 0.0038
82 BRONCHITIS CHRONIC 9 0.0037
83 CARBON DIOXIDE INCREASED 5 0.0037
84 HYPERPARATHYROIDISM SECONDARY 9 0.0036
85 ESSENTIAL TREMOR 4 0.0036
86 LUNG CONSOLIDATION 10 0.0036
87 LOWER RESPIRATORY TRACT CONGESTION 6 0.0035
88 WRIST FRACTURE 39 0.0033
89 RESPIRATORY TRACT INFECTION 84 0.0032
90 RESPIRATION ABNORMAL 22 0.0032
91 LEFT ATRIAL DILATATION 4 0.0031
92 INCREASED BRONCHIAL SECRETION 8 0.0031
93 PRODUCTIVE COUGH 142 0.0030
94 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 25 0.0028
95 BODY HEIGHT DECREASED 30 0.0028
96 SECRETION DISCHARGE 35 0.0028
97 CLAUSTROPHOBIA 3 0.0027
98 INCREASED UPPER AIRWAY SECRETION 14 0.0027
99 ASTHMA 307 0.0027
100 GASTROINTESTINAL ULCER HAEMORRHAGE 3 0.0027
101 NEPHROGENIC ANAEMIA 12 0.0026
102 VOCAL CORD DISORDER 5 0.0025
103 ANTIPHOSPHOLIPID SYNDROME 4 0.0025
104 OXYGEN SATURATION ABNORMAL 7 0.0025
105 POLYP 16 0.0024
106 TYMPANIC MEMBRANE PERFORATION 4 0.0024
107 FOOD AVERSION 4 0.0024
108 ACUTE RESPIRATORY FAILURE 45 0.0023
109 POOR VENOUS ACCESS 24 0.0023
110 INFUSION SITE BRUISING 5 0.0023
111 SENSITIVITY TO WEATHER CHANGE 12 0.0023
112 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 162 0.0023
113 MIDDLE EAR EFFUSION 5 0.0023
114 ACROCHORDON 3 0.0023
115 SKIN WEEPING 8 0.0022
116 CALCINOSIS 5 0.0022
117 RESPIRATORY TRACT CONGESTION 35 0.0022
118 CLUSTER HEADACHE 3 0.0022
119 INFUSION SITE RASH 3 0.0022
120 SEBORRHOEA 8 0.0022
121 BODY TEMPERATURE ABNORMAL 4 0.0022
122 DISCHARGE 3 0.0022
123 WOUND DEHISCENCE 7 0.0021
124 INFUSION SITE SWELLING 13 0.0021
125 LUNG DISORDER 101 0.0021
126 PULMONARY PAIN 6 0.0021
127 DECREASED INTEREST 12 0.0020
128 BLOOD PRESSURE DIASTOLIC INCREASED 9 0.0019
129 EOSINOPHIL COUNT INCREASED 16 0.0019
130 BRONCHITIS 142 0.0019
131 INFUSION SITE PRURITUS 6 0.0019
132 DYSPNOEA 1075 0.0019
133 PAIN OF SKIN 51 0.0019
134 DYSPNOEA EXERTIONAL 70 0.0019
135 UPPER LIMB FRACTURE 37 0.0019
136 CANDIDA INFECTION 31 0.0018
137 INSURANCE ISSUE 28 0.0018
138 INFUSION SITE HAEMORRHAGE 6 0.0018
139 ANXIETY DISORDER 6 0.0018
140 BLOOD TEST ABNORMAL 25 0.0018
141 PNEUMOTHORAX 28 0.0018
142 OBSTRUCTION 7 0.0018
143 HYPOPNOEA 6 0.0017
144 HAEMOTHORAX 5 0.0017
145 OXYGEN SATURATION DECREASED 96 0.0017
146 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 82 0.0017
147 APPARENT DEATH 6 0.0017
148 PAINFUL RESPIRATION 4 0.0017
149 REBOUND ACID HYPERSECRETION 5 0.0017
150 INTERVERTEBRAL DISC PROTRUSION 36 0.0016
151 PSYCHIATRIC SYMPTOM 12 0.0016
152 CARTILAGE INJURY 4 0.0016
153 HEART RATE ABNORMAL 9 0.0016
154 WEIGHT DECREASED 450 0.0016
155 INABILITY TO AFFORD MEDICATION 16 0.0016
156 BLOOD CHOLESTEROL DECREASED 3 0.0016
157 FLUID INTAKE REDUCED 8 0.0016
158 ORTHOPNOEA 5 0.0016
159 CUSHINGOID 5 0.0016
160 SEASONAL ALLERGY 22 0.0016
161 TACHYPNOEA 21 0.0015
162 RHINOVIRUS INFECTION 6 0.0015
163 HYPERTHYROIDISM 22 0.0015
164 UPPER RESPIRATORY TRACT INFECTION 70 0.0015
165 PNEUMONIA 486 0.0015
166 MIDDLE INSOMNIA 28 0.0015
167 SKIN FISSURES 29 0.0015
168 EOSINOPHILIA 26 0.0015
169 VITAMIN B12 DEFICIENCY 6 0.0015
170 SLEEP APNOEA SYNDROME 28 0.0015
171 SINUS DISORDER 29 0.0015
172 THERAPEUTIC RESPONSE SHORTENED 48 0.0014
173 ATRIAL TACHYCARDIA 3 0.0014
174 SNEEZING 32 0.0014
175 BODY TEMPERATURE DECREASED 14 0.0014
176 PNEUMONIA BACTERIAL 13 0.0014
177 FREQUENT BOWEL MOVEMENTS 38 0.0014
178 ELECTROCARDIOGRAM ABNORMAL 11 0.0014
179 EXOPHTHALMOS 3 0.0014
180 INFECTION SUSCEPTIBILITY INCREASED 3 0.0014
181 PULMONARY CONGESTION 18 0.0014
182 DRUG PRESCRIBING ERROR 26 0.0014
183 LOWER GASTROINTESTINAL HAEMORRHAGE 10 0.0014
184 LUNG INFECTION 21 0.0014
185 COUGH 379 0.0014
186 RHINITIS ALLERGIC 6 0.0013
187 ANAL INCONTINENCE 12 0.0013
188 PARANASAL SINUS DISCOMFORT 5 0.0013
189 FOOD POISONING 7 0.0013
190 INSOMNIA 344 0.0013
191 INFUSION SITE EXTRAVASATION 8 0.0013
192 CONTRAST MEDIA REACTION 3 0.0013
193 DERMATITIS ATOPIC 67 0.0013
194 RESPIRATORY DISORDER 38 0.0013
195 PNEUMONIA FUNGAL 5 0.0013
196 PRODUCT PHYSICAL CONSISTENCY ISSUE 7 0.0013
197 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO DEVICE USE ERROR 3 0.0013
198 DECREASED APPETITE 293 0.0013
199 WEIGHT FLUCTUATION 13 0.0012
200 SENSITIVE SKIN 9 0.0012
201 SKIN ATROPHY 7 0.0012
202 INTENTIONAL PRODUCT MISUSE 106 0.0012
203 GASTROOESOPHAGEAL REFLUX DISEASE 96 0.0012
204 COLD SWEAT 21 0.0012
205 BRONCHOSPASM 17 0.0012
206 BLOOD GLUCOSE FLUCTUATION 13 0.0012
207 CHEMICAL BURN OF SKIN 3 0.0012
208 BLOOD PRESSURE DIASTOLIC ABNORMAL 3 0.0012
209 PRODUCT PRESCRIBING ERROR 28 0.0012
210 PNEUMONITIS 32 0.0012
211 CHEST DISCOMFORT 120 0.0012
212 HEART RATE INCREASED 115 0.0012
213 CATHETER SITE PAIN 3 0.0012
214 FEELING JITTERY 22 0.0012
215 MICTURITION DISORDER 4 0.0012
216 SUPRAVENTRICULAR TACHYCARDIA 11 0.0011
217 TREMOR 190 0.0011
218 EAR PRURITUS 4 0.0011
219 DERMATITIS CONTACT 13 0.0011
220 ORAL CANDIDIASIS 15 0.0011
221 HAEMORRHAGIC ANAEMIA 5 0.0011
222 EATING DISORDER 24 0.0011
223 SUICIDAL IDEATION 103 0.0011
224 SENSORY DISTURBANCE 18 0.0011
225 FEAR OF INJECTION 8 0.0011
226 BLOOD COUNT ABNORMAL 17 0.0011
227 STENT PLACEMENT 9 0.0011
228 ABDOMINAL HERNIA 5 0.0011
229 UPPER-AIRWAY COUGH SYNDROME 9 0.0011
230 MACULAR DEGENERATION 13 0.0011
231 INFUSION SITE PAIN 14 0.0011
232 CYSTIC FIBROSIS 6 0.0011
233 PRODUCT DISTRIBUTION ISSUE 10 0.0011
234 ARTHRITIS INFECTIVE 5 0.0011
235 SKIN BURNING SENSATION 77 0.0011
236 DRUG TOLERANCE DECREASED 3 0.0011
237 IMPULSIVE BEHAVIOUR 4 0.0011
238 SKIN TOXICITY 6 0.0011
239 SNORING 4 0.0011
240 SKIN ABRASION 5 0.0011
241 NEUTROPHILIA 6 0.0011
242 PSEUDOMONAS INFECTION 9 0.0010
243 PARANASAL SINUS HYPERSECRETION 4 0.0010
244 OSTEOPOROSIS 43 0.0010
245 PANIC ATTACK 38 0.0010
246 EXERCISE TOLERANCE DECREASED 6 0.0010
247 RESPIRATORY FAILURE 76 0.0010
248 NASAL CONGESTION 61 0.0010
249 POSTOPERATIVE WOUND INFECTION 7 0.0010
250 SINUS CONGESTION 14 0.0010
251 ECZEMA 54 0.0010
252 ABNORMAL LOSS OF WEIGHT 7 0.0010
253 HAEMORRHOIDAL HAEMORRHAGE 5 0.0010
254 CATARACT OPERATION 6 0.0010
255 INFLUENZA 112 0.0010
256 HAEMOPTYSIS 28 0.0010
257 ATYPICAL PNEUMONIA 3 0.0010
258 HYPOACUSIS 43 0.0010
259 LUNG ADENOCARCINOMA 3 0.0010
260 BACK PAIN 230 0.0010
261 ADRENAL INSUFFICIENCY 12 0.0010
262 OSTEOPENIA 15 0.0010
263 APPLICATION SITE DISCOLOURATION 4 0.0010
264 DRY THROAT 10 0.0010
265 CARDIAC FAILURE CONGESTIVE 78 0.0010
266 PARAESTHESIA ORAL 14 0.0010
267 SUICIDAL BEHAVIOUR 4 0.0010
268 INVESTIGATION 3 0.0010
269 DIARRHOEA 611 0.0009
270 SKIN HAEMORRHAGE 14 0.0009
271 ANORECTAL DISCOMFORT 5 0.0009
272 LEFT VENTRICULAR HYPERTROPHY 4 0.0009
273 SKIN HYPERPIGMENTATION 8 0.0009
274 HAEMATOCHEZIA 51 0.0009
275 BREAST ENLARGEMENT 3 0.0009
276 BOWEL MOVEMENT IRREGULARITY 7 0.0009
277 INFLUENZA LIKE ILLNESS 75 0.0009
278 PROSTATIC DISORDER 5 0.0009
279 RESPIRATORY DISTRESS 25 0.0009
280 BLOOD PRESSURE ABNORMAL 18 0.0009
281 APPETITE DISORDER 6 0.0009
282 LOW DENSITY LIPOPROTEIN INCREASED 7 0.0009
283 SKIN EXFOLIATION 76 0.0009
284 SPINAL FRACTURE 18 0.0009
285 RHINORRHOEA 58 0.0009
286 ARTERIAL OCCLUSIVE DISEASE 7 0.0009
287 IRON DEFICIENCY 4 0.0009
288 CLOSTRIDIAL INFECTION 3 0.0009
289 TRICUSPID VALVE INCOMPETENCE 7 0.0009
290 NERVOUSNESS 46 0.0009
291 EAR DISCOMFORT 9 0.0009
292 LEFT VENTRICULAR FAILURE 3 0.0009
293 ABNORMAL DREAMS 24 0.0009
294 RHINITIS 7 0.0009
295 FUNCTIONAL GASTROINTESTINAL DISORDER 3 0.0009
296 BLOOD CHOLESTEROL ABNORMAL 4 0.0009
297 DEATH 745 0.0009
298 HYPERVENTILATION 5 0.0009
299 CONJUNCTIVITIS 16 0.0009
300 DEFAECATION URGENCY 6 0.0009
301 UMBILICAL HERNIA 4 0.0009
302 SPINAL PAIN 10 0.0009
303 COVID-19 PNEUMONIA 10 0.0008
304 HAEMORRHAGE SUBCUTANEOUS 3 0.0008
305 RETCHING 18 0.0008
306 TACHYCARDIA 75 0.0008
307 BLOOD URINE PRESENT 16 0.0008
308 PLEURISY 5 0.0008
309 SINUS HEADACHE 5 0.0008
310 MUSCULOSKELETAL CHEST PAIN 13 0.0008
311 ILLNESS 86 0.0008
312 GASTROENTERITIS VIRAL 15 0.0008
313 GUILLAIN-BARRE SYNDROME 4 0.0008
314 ERUCTATION 16 0.0008
315 EAR INFECTION 22 0.0008
316 PULMONARY THROMBOSIS 9 0.0008
317 INFLAMMATORY BOWEL DISEASE 8 0.0008
318 OBESITY 13 0.0008
319 MUSCULOSKELETAL DISCOMFORT 14 0.0008
320 DEPRESSED MOOD 43 0.0008
321 EXPOSURE VIA SKIN CONTACT 21 0.0008
322 HOSPICE CARE 8 0.0008
323 MUSCLE STRAIN 7 0.0008
324 MUCOUS STOOLS 4 0.0008
325 SKIN SWELLING 7 0.0008
326 NASAL DRYNESS 5 0.0008
327 HYPOAESTHESIA ORAL 12 0.0008
328 SLEEP DISORDER 56 0.0008
329 FOOT FRACTURE 15 0.0008
330 SINUSITIS 81 0.0008
331 AORTIC ANEURYSM 6 0.0008
332 DEVICE FAILURE 12 0.0008
333 GASTRIC INFECTION 3 0.0008
334 GINGIVAL DISORDER 3 0.0008
335 ATRIOVENTRICULAR BLOCK 6 0.0008
336 NASOPHARYNGITIS 143 0.0008
337 BENIGN PROSTATIC HYPERPLASIA 4 0.0008
338 APPLICATION SITE PAIN 17 0.0008
339 INTENTIONAL DOSE OMISSION 22 0.0008
340 DYSPHONIA 45 0.0008
341 EPIGASTRIC DISCOMFORT 3 0.0008
342 PULMONARY HAEMORRHAGE 6 0.0008
343 PARTIAL SEIZURES 4 0.0008
344 FOLLICULITIS 8 0.0008
345 DYSGRAPHIA 5 0.0008
346 DEPRESSION 172 0.0008
347 LUNG NEOPLASM MALIGNANT 31 0.0008
348 HEART RATE IRREGULAR 17 0.0008
349 CHRONIC KIDNEY DISEASE 57 0.0007
350 COMPRESSION FRACTURE 4 0.0007
351 HOMICIDAL IDEATION 3 0.0007
352 CONDITION AGGRAVATED 224 0.0007
353 THROAT IRRITATION 33 0.0007
354 BLOOD POTASSIUM DECREASED 22 0.0007
355 ATRIAL FIBRILLATION 71 0.0007
356 NONSPECIFIC REACTION 4 0.0007
357 ASTHENOPIA 4 0.0007
358 CHOKING SENSATION 4 0.0007
359 CYST 9 0.0007
360 PULMONARY HYPERTENSION 15 0.0007
361 ANXIETY 204 0.0007
362 APHONIA 10 0.0007
363 BONE DISORDER 13 0.0007
364 PRODUCT LEAKAGE 4 0.0007
365 END STAGE RENAL DISEASE 13 0.0007
366 ATTENTION DEFICIT HYPERACTIVITY DISORDER 3 0.0007
367 INFUSION SITE ERYTHEMA 6 0.0007
368 HEADACHE 444 0.0007
369 DRUG DOSE OMISSION 117 0.0007
370 PERIORBITAL SWELLING 4 0.0007
371 INCORRECT DRUG ADMINISTRATION RATE 3 0.0007
372 CARDIAC FAILURE CHRONIC 3 0.0007
373 PRODUCT CONTAINER ISSUE 6 0.0007
374 HORDEOLUM 3 0.0007
375 OROPHARYNGEAL PAIN 64 0.0007
376 SKIN DISORDER 23 0.0007
377 RESPIRATORY SYNCYTIAL VIRUS INFECTION 6 0.0007
378 SKIN WARM 4 0.0007
379 EYE PRURITUS 23 0.0007
380 DYSPHEMIA 3 0.0007
381 DEVICE MALFUNCTION 48 0.0007
382 CATHETERISATION CARDIAC 3 0.0007
383 BLOOD IRON DECREASED 8 0.0007
384 BLOOD PRESSURE INCREASED 103 0.0007
385 MALAISE 295 0.0007
386 PRODUCT DOSE OMISSION IN ERROR 19 0.0007
387 ACCIDENT 8 0.0007
388 GOUT 12 0.0007
389 TRANSFUSION 7 0.0007
390 KIDNEY INFECTION 13 0.0007
391 LOCALISED INFECTION 16 0.0007
392 CHEST PAIN 122 0.0007
393 ILL-DEFINED DISORDER 40 0.0007
394 PALPITATIONS 77 0.0007
395 RESTLESSNESS 24 0.0007
396 DISEASE COMPLICATION 3 0.0007
397 JOINT INJURY 14 0.0007
398 PRODUCT QUALITY ISSUE 89 0.0007
399 EAR DISORDER 3 0.0007
400 LUMBAR VERTEBRAL FRACTURE 3 0.0007
401 DRY SKIN 87 0.0007
402 DECREASED ACTIVITY 7 0.0006
403 BACTERIAL INFECTION 12 0.0006
404 NEPHROPATHY 6 0.0006
405 PELVIC FRACTURE 5 0.0006
406 NAUSEA 508 0.0006
407 FLANK PAIN 6 0.0006
408 OEDEMA PERIPHERAL 78 0.0006
409 ASPIRATION 7 0.0006
410 LACERATION 6 0.0006
411 DIZZINESS 318 0.0006
412 INTESTINAL OBSTRUCTION 24 0.0006
413 MELAENA 14 0.0006
414 FLATULENCE 36 0.0006
415 CRYING 23 0.0006
416 ABDOMINAL PAIN LOWER 16 0.0006
417 RIB FRACTURE 13 0.0006
418 SWELLING FACE 41 0.0006
419 NERVE INJURY 7 0.0006
420 HYPERSOMNIA 18 0.0006
421 ATRIAL FLUTTER 5 0.0006
422 HYPOVOLAEMIC SHOCK 3 0.0006
423 BLOOD PRESSURE FLUCTUATION 15 0.0006
424 HYPOXIA 22 0.0006
425 FAECAL INCONTINENCE 3 0.0006
426 POLLAKIURIA 26 0.0006
427 HYPERTENSION 132 0.0006
428 HAEMOGLOBIN ABNORMAL 4 0.0006
429 CATARACT 37 0.0006
430 EYE INFECTION 7 0.0006
431 FRUSTRATION TOLERANCE DECREASED 5 0.0006
432 CARDIAC FLUTTER 4 0.0006
433 VITAMIN D DEFICIENCY 6 0.0006
434 BACK DISORDER 10 0.0006
435 HEPATOMEGALY 6 0.0006
436 ABNORMAL FAECES 5 0.0006
437 PRODUCT PREPARATION ISSUE 4 0.0006
438 DISEASE RECURRENCE 29 0.0006
439 ASPERGILLUS INFECTION 4 0.0006
440 NECK PAIN 34 0.0006
441 GASTRITIS 16 0.0006
442 VENTRICULAR TACHYCARDIA 10 0.0006
443 CORONAVIRUS INFECTION 4 0.0006
444 RESTLESS LEGS SYNDROME 11 0.0006
445 MEMORY IMPAIRMENT 83 0.0006
446 POOR QUALITY SLEEP 13 0.0006
447 HYPERNATRAEMIA 3 0.0006
448 FEELING ABNORMAL 144 0.0006
449 CARDIAC FAILURE ACUTE 4 0.0006
450 SKIN MASS 4 0.0006
451 CLOSTRIDIUM DIFFICILE INFECTION 13 0.0006
452 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 107 0.0006
453 MEDICATION ERROR 33 0.0006
454 ANGINA PECTORIS 17 0.0006
455 PRODUCT TASTE ABNORMAL 8 0.0006
456 BACTERAEMIA 7 0.0006
457 PSORIASIS 77 0.0006
458 ABDOMINAL DISCOMFORT 97 0.0006
459 CARDIAC MURMUR 5 0.0006
460 FAILURE TO THRIVE 3 0.0006
461 VENTRICULAR EXTRASYSTOLES 6 0.0006
462 LARGE INTESTINE POLYP 4 0.0006
463 THERAPEUTIC RESPONSE DECREASED 35 0.0006
464 BASAL CELL CARCINOMA 9 0.0006
465 NEURALGIA 14 0.0006
466 DERMATITIS 12 0.0006
467 INJECTION SITE URTICARIA 14 0.0006
468 FUNGAL INFECTION 19 0.0006
469 GROIN PAIN 5 0.0006
470 HERNIA 11 0.0006
471 SCRATCH 6 0.0006
472 PRURITUS 217 0.0006
473 BLOOD PRESSURE SYSTOLIC INCREASED 11 0.0006
474 CHOKING 11 0.0006
475 ORAL HERPES 11 0.0006
476 BREAST PAIN 6 0.0006
477 ANAL ABSCESS 3 0.0006
478 IMPAIRED QUALITY OF LIFE 8 0.0006
479 CHEILITIS 3 0.0006
480 PANIC REACTION 4 0.0006
481 LIMB INJURY 15 0.0006
482 SKIN LACERATION 6 0.0006
483 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 3 0.0006
484 MOOD ALTERED 15 0.0005
485 LOWER RESPIRATORY TRACT INFECTION 25 0.0005
486 HIDRADENITIS 5 0.0005
487 ASTHENIA 206 0.0005
488 DEAFNESS UNILATERAL 3 0.0005
489 TOOTH FRACTURE 6 0.0005
490 SKIN DISCOLOURATION 25 0.0005
491 RETINAL DETACHMENT 5 0.0005
492 RENAL FAILURE 72 0.0005
493 BLOOD PRESSURE DIASTOLIC DECREASED 4 0.0005
494 VIRAL INFECTION 18 0.0005
495 CEREBRAL DISORDER 4 0.0005
496 FEELING DRUNK 4 0.0005
497 PRODUCT DOSE OMISSION ISSUE 158 0.0005
498 MALNUTRITION 6 0.0005
499 DIARRHOEA HAEMORRHAGIC 5 0.0005
500 OEDEMA 29 0.0005
501 OCULAR DISCOMFORT 6 0.0005
502 MOOD SWINGS 17 0.0005
503 BEDRIDDEN 7 0.0005
504 PERIPHERAL SWELLING 82 0.0005
505 OFF LABEL USE 465 0.0005
506 REBOUND EFFECT 6 0.0005
507 COVID-19 93 0.0005
508 PRODUCT USE ISSUE 99 0.0005
509 INTERNAL HAEMORRHAGE 6 0.0005
510 CARDIAC DISORDER 49 0.0005
511 PSORIATIC ARTHROPATHY 21 0.0005
512 DEHYDRATION 69 0.0005
513 CONCUSSION 4 0.0005
514 DYSURIA 19 0.0005
515 DEVICE USE ISSUE 9 0.0005
516 HAEMORRHAGIC STROKE 4 0.0005
517 FEELING OF BODY TEMPERATURE CHANGE 3 0.0005
518 BLOOD TRIGLYCERIDES INCREASED 9 0.0005
519 BRADYKINESIA 3 0.0005
520 PRODUCT DOSE OMISSION 33 0.0005
521 HERPES ZOSTER 29 0.0005
522 NASAL DISCOMFORT 4 0.0005
523 RENAL CYST 4 0.0005
524 CARDIAC PACEMAKER INSERTION 3 0.0005
525 HYPERLIPIDAEMIA 6 0.0005
526 SCIATICA 8 0.0005
527 MASS 7 0.0005
528 ABDOMINAL PAIN UPPER 103 0.0005
529 HEARING IMPAIRED 3 0.0005
530 CONTUSION 48 0.0005
531 BLOOD PRESSURE DECREASED 33 0.0005
532 LACRIMATION INCREASED 15 0.0005
533 INJECTION SITE VESICLES 3 0.0005
534 PRODUCT ADMINISTRATION ERROR 10 0.0005
535 FEEDING DISORDER 10 0.0005
536 BLOOD POTASSIUM INCREASED 8 0.0005
537 POST PROCEDURAL INFECTION 4 0.0005
538 HALLUCINATION 37 0.0005
539 INITIAL INSOMNIA 5 0.0005
540 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 5 0.0005
541 URINARY TRACT INFECTION 83 0.0005
542 ESCHERICHIA INFECTION 4 0.0005
543 ABASIA 12 0.0005
544 TEMPERATURE INTOLERANCE 5 0.0005
545 PULMONARY ARTERIAL HYPERTENSION 7 0.0005
546 PAIN IN EXTREMITY 142 0.0005
547 EYE DISCHARGE 5 0.0005
548 AGEUSIA 12 0.0005
549 DRY EYE 24 0.0005
550 SKIN IRRITATION 22 0.0005
551 TENDERNESS 5 0.0005
552 MUSCLE SPASMS 88 0.0005
553 GASTROINTESTINAL HAEMORRHAGE 40 0.0005
554 FALL 159 0.0005
555 INFECTION 69 0.0005
556 DEVICE DELIVERY SYSTEM ISSUE 13 0.0005
557 HEAD INJURY 15 0.0005
558 CARDIAC FAILURE 38 0.0005
559 URINARY INCONTINENCE 14 0.0005
560 DRUG EFFECT LESS THAN EXPECTED 7 0.0005
561 CLOSTRIDIUM DIFFICILE COLITIS 5 0.0005
562 HYPOPHAGIA 12 0.0005
563 PULMONARY FIBROSIS 9 0.0005
564 GASTROINTESTINAL DISORDER 42 0.0005
565 HYPOTENSION 94 0.0005
566 LOWER LIMB FRACTURE 9 0.0005
567 HIP FRACTURE 15 0.0005
568 RECTAL HAEMORRHAGE 20 0.0005
569 BLOOD MAGNESIUM DECREASED 4 0.0005
570 MYOPATHY 4 0.0005
571 EAR PAIN 9 0.0005
572 NIGHTMARE 16 0.0005
573 BACK INJURY 5 0.0005
574 VISION BLURRED 63 0.0005
575 INCORRECT DOSE ADMINISTERED BY DEVICE 12 0.0005
576 RASH MACULAR 16 0.0005
577 PRODUCT USE IN UNAPPROVED INDICATION 113 0.0005
578 EPISTAXIS 34 0.0005
579 THYROID DISORDER 7 0.0005
580 ARTERIOSCLEROSIS CORONARY ARTERY 3 0.0005
581 HEAD DISCOMFORT 8 0.0005
582 NEOPLASM MALIGNANT 30 0.0004
583 GASTROINTESTINAL INFECTION 4 0.0004
584 BLISTER 25 0.0004
585 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 15 0.0004
586 OROPHARYNGEAL DISCOMFORT 4 0.0004
587 BURNING SENSATION 31 0.0004
588 MUSCULAR WEAKNESS 50 0.0004
589 CYSTITIS 14 0.0004
590 PRODUCT AVAILABILITY ISSUE 10 0.0004
591 ECCHYMOSIS 3 0.0004
592 CORONARY ARTERY OCCLUSION 6 0.0004
593 GASTRIC DISORDER 15 0.0004
594 CELLULITIS 22 0.0004
595 GASTRIC HAEMORRHAGE 5 0.0004
596 NERVE COMPRESSION 4 0.0004
597 INTERVERTEBRAL DISC DEGENERATION 4 0.0004
598 NEUROPATHY PERIPHERAL 41 0.0004
599 PERSONALITY CHANGE 4 0.0004
600 ARTERIOSCLEROSIS 4 0.0004
601 DRUG INTOLERANCE 41 0.0004
602 BLOOD SODIUM DECREASED 8 0.0004
603 THERAPEUTIC PRODUCT EFFECT DECREASED 19 0.0004
604 DRUG ADMINISTRATION ERROR 13 0.0004
605 HAND FRACTURE 3 0.0004
606 THERAPY NON-RESPONDER 19 0.0004
607 DIVERTICULUM 3 0.0004
608 DEAFNESS 11 0.0004
609 SWOLLEN TONGUE 13 0.0004
610 UPPER GASTROINTESTINAL HAEMORRHAGE 7 0.0004
611 HYPERCHOLESTEROLAEMIA 4 0.0004
612 ATELECTASIS 4 0.0004
613 FAECES SOFT 3 0.0004
614 DIZZINESS POSTURAL 4 0.0004
615 BURSITIS 5 0.0004
616 GASTROENTERITIS 6 0.0004
617 CIRCULATORY COLLAPSE 7 0.0004
618 UNEVALUABLE EVENT 31 0.0004
619 BONE PAIN 24 0.0004
620 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 12 0.0004
621 THERAPY CESSATION 21 0.0004
622 FEAR 11 0.0004
623 SCAR 7 0.0004
624 VITREOUS FLOATERS 4 0.0004
625 ARTHRITIS 32 0.0004
626 DYSPEPSIA 40 0.0004
627 GENERAL PHYSICAL HEALTH DETERIORATION 47 0.0004
628 PARANOIA 7 0.0004
629 CARDIOMYOPATHY 6 0.0004
630 ACTIVITIES OF DAILY LIVING IMPAIRED 8 0.0004
631 RENAL INJURY 12 0.0004
632 PHARYNGITIS 5 0.0004
633 PULMONARY OEDEMA 18 0.0004
634 HAIR COLOUR CHANGES 5 0.0004
635 LOCAL SWELLING 7 0.0004
636 SKIN LESION 11 0.0004
637 CHILLS 47 0.0004
638 GENERAL SYMPTOM 3 0.0004
639 HEART RATE DECREASED 14 0.0004
640 DIVERTICULITIS 11 0.0004
641 CONFUSIONAL STATE 64 0.0004
642 EXTRA DOSE ADMINISTERED 16 0.0004
643 DRY MOUTH 32 0.0004
644 TASTE DISORDER 8 0.0004
645 SLUGGISHNESS 4 0.0004
646 INJECTION SITE RASH 12 0.0004
647 FATIGUE 304 0.0004
648 PHARYNGEAL OEDEMA 6 0.0004
649 FOOD ALLERGY 3 0.0004
650 PAIN IN JAW 11 0.0004
651 MIGRAINE 37 0.0004
652 ABDOMINAL PAIN 90 0.0004
653 TOOTHACHE 7 0.0004
654 HIATUS HERNIA 5 0.0004
655 THERAPY PARTIAL RESPONDER 6 0.0004
656 WEIGHT INCREASED 86 0.0004
657 ABDOMINAL DISTENSION 40 0.0004
658 BRAIN FOG 6 0.0004
659 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 21 0.0004
660 MUSCULOSKELETAL PAIN 20 0.0004
661 ARRHYTHMIA 18 0.0004
662 HAEMATURIA 13 0.0004
663 IMMUNE SYSTEM DISORDER 5 0.0004
664 SUICIDE ATTEMPT 23 0.0004
665 TOOTH INFECTION 5 0.0004
666 VISUAL IMPAIRMENT 47 0.0004
667 INJECTION SITE MASS 14 0.0004
668 FURUNCLE 3 0.0004
669 JOINT DISLOCATION 4 0.0004
670 THERAPY INTERRUPTED 27 0.0004
671 DISCOMFORT 23 0.0004
672 DYSGEUSIA 28 0.0004
673 DYSSTASIA 11 0.0004
674 HYPOTHYROIDISM 12 0.0004
675 THINKING ABNORMAL 7 0.0004
676 FEELING HOT 23 0.0004
677 BLOOD DISORDER 3 0.0004
678 FLUID RETENTION 19 0.0004
679 THROMBOSIS 30 0.0004
680 HYPONATRAEMIA 21 0.0004
681 QUALITY OF LIFE DECREASED 5 0.0004
682 HOSPITALISATION 57 0.0004
683 DISTURBANCE IN ATTENTION 20 0.0004
684 PRURITUS GENERALISED 8 0.0004
685 THROAT TIGHTNESS 10 0.0004
686 PHARYNGITIS STREPTOCOCCAL 4 0.0004
687 HYPOKALAEMIA 17 0.0004
688 MENTAL DISORDER 16 0.0004
689 IMPAIRED GASTRIC EMPTYING 5 0.0004
690 INCREASED APPETITE 7 0.0004
691 ARTHRALGIA 152 0.0004
692 INTENTIONAL PRODUCT USE ISSUE 32 0.0004
693 MULTIPLE FRACTURES 6 0.0004
694 EYE IRRITATION 21 0.0004
695 GASTROINTESTINAL PAIN 4 0.0004
696 CORONARY ARTERY DISEASE 11 0.0004
697 ELECTROCARDIOGRAM QT PROLONGED 13 0.0004
698 TOOTH DISORDER 8 0.0004
699 URINARY RETENTION 12 0.0004
700 RASH 156 0.0004
701 DEMENTIA 10 0.0004
702 THERAPEUTIC RESPONSE UNEXPECTED 16 0.0004
703 PANCREATITIS ACUTE 8 0.0004
704 BLOOD CALCIUM DECREASED 4 0.0004
705 BLINDNESS UNILATERAL 5 0.0004
706 DISABILITY 7 0.0004
707 SCAB 4 0.0004
708 EYE SWELLING 13 0.0003
709 SKIN ULCER 9 0.0003
710 DRUG INEFFECTIVE 457 0.0003
711 DRUG INTERACTION 55 0.0003
712 HYSTERECTOMY 3 0.0003
713 ANAEMIA 66 0.0003
714 PERICARDIAL EFFUSION 8 0.0003
715 DEVICE ISSUE 31 0.0003
716 HYPOKINESIA 5 0.0003
717 ELECTROLYTE IMBALANCE 4 0.0003
718 CONSTIPATION 75 0.0003
719 APPLICATION SITE ERYTHEMA 9 0.0003
720 VASCULITIS 4 0.0003
721 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 16 0.0003
722 ERYTHEMA 70 0.0003
723 INJECTION SITE SWELLING 26 0.0003
724 MYOCARDIAL INFARCTION 59 0.0003
725 AMNESIA 22 0.0003
726 PARAESTHESIA 53 0.0003
727 COLON CANCER 5 0.0003
728 IMMUNODEFICIENCY 5 0.0003
729 EYE DISORDER 11 0.0003
730 HYPERSENSITIVITY 62 0.0003
731 VOMITING 157 0.0003
732 LEUKOCYTOSIS 6 0.0003
733 HALLUCINATION, VISUAL 7 0.0003
734 LIP DRY 3 0.0003
735 RENAL FAILURE ACUTE 14 0.0003
736 SCHIZOPHRENIA 4 0.0003
737 DRUG DISPENSING ERROR 5 0.0003
738 AGITATION 24 0.0003
739 HIP ARTHROPLASTY 5 0.0003
740 INCREASED TENDENCY TO BRUISE 3 0.0003
741 TREATMENT FAILURE 27 0.0003
742 ANGER 11 0.0003
743 SKIN CANCER 7 0.0003
744 IRON DEFICIENCY ANAEMIA 3 0.0003
745 SMALL INTESTINAL OBSTRUCTION 4 0.0003
746 GENERALISED OEDEMA 4 0.0003
747 SOMNOLENCE 65 0.0003
748 URTICARIA 54 0.0003
749 WOUND 9 0.0003
750 APPENDICITIS 3 0.0003
751 SWELLING 30 0.0003
752 PNEUMONIA ASPIRATION 8 0.0003
753 PHOTOPHOBIA 6 0.0003
754 LEUKAEMIA 3 0.0003
755 MYALGIA 54 0.0003
756 HAEMORRHAGE 33 0.0003
757 SEPSIS 35 0.0003
758 INTRAOCULAR PRESSURE INCREASED 4 0.0003
759 GLAUCOMA 6 0.0003
760 ROTATOR CUFF SYNDROME 4 0.0003
761 TREATMENT NONCOMPLIANCE 17 0.0003
762 MUSCLE TIGHTNESS 5 0.0003
763 INJECTION SITE INDURATION 4 0.0003
764 APPLICATION SITE PRURITUS 7 0.0003
765 HAEMORRHOIDS 6 0.0003
766 COELIAC DISEASE 3 0.0003
767 ACUTE MYOCARDIAL INFARCTION 9 0.0003
768 ANKYLOSING SPONDYLITIS 4 0.0003
769 ABNORMAL BEHAVIOUR 12 0.0003
770 PHOTOSENSITIVITY REACTION 5 0.0003
771 INCORRECT DOSE ADMINISTERED 69 0.0003
772 BLADDER DISORDER 3 0.0003
773 DRUG LEVEL INCREASED 5 0.0003
774 DIABETES MELLITUS 23 0.0003
775 ACCIDENTAL EXPOSURE TO PRODUCT 31 0.0003
776 BLOOD CHOLESTEROL INCREASED 14 0.0003
777 HAIR TEXTURE ABNORMAL 4 0.0003
778 JOINT SWELLING 36 0.0003
779 GAIT DISTURBANCE 57 0.0003
780 PRODUCT PHYSICAL ISSUE 6 0.0003
781 LOSS OF CONSCIOUSNESS 38 0.0003
782 TRANSIENT ISCHAEMIC ATTACK 10 0.0003
783 PLEURAL EFFUSION 18 0.0003
784 VERTIGO 18 0.0003
785 ADVERSE EVENT 27 0.0003
786 MOBILITY DECREASED 21 0.0003
787 INJECTION SITE WARMTH 6 0.0003
788 COLITIS 11 0.0003
789 ADVERSE DRUG REACTION 26 0.0003
790 PAIN 177 0.0003
791 MENTAL STATUS CHANGES 8 0.0003
792 FEELING COLD 8 0.0003
793 HUNGER 4 0.0003
794 INCONTINENCE 3 0.0003
795 DIABETES MELLITUS INADEQUATE CONTROL 5 0.0003
796 IRRITABLE BOWEL SYNDROME 6 0.0003
797 INCORRECT ROUTE OF DRUG ADMINISTRATION 10 0.0003
798 HOT FLUSH 21 0.0003
799 DISORIENTATION 11 0.0003
800 INCORRECT PRODUCT ADMINISTRATION DURATION 6 0.0003
801 GASTRIC CANCER 7 0.0003
802 PELVIC PAIN 5 0.0003
803 FLUID OVERLOAD 4 0.0003
804 PYREXIA 95 0.0003
805 BLOOD GLUCOSE ABNORMAL 5 0.0003
806 INJECTION SITE PAIN 83 0.0003
807 DIPLOPIA 7 0.0003
808 COLITIS ULCERATIVE 12 0.0003
809 GLOSSODYNIA 6 0.0003
810 ORAL PAIN 6 0.0003
811 ACUTE KIDNEY INJURY 41 0.0003
812 SPEECH DISORDER 14 0.0003
813 TUBULOINTERSTITIAL NEPHRITIS 5 0.0003
814 CARDIAC ARREST 22 0.0003
815 EYE PAIN 15 0.0003
816 PANCREATITIS 14 0.0003
817 CHOLECYSTECTOMY 3 0.0003
818 RENAL IMPAIRMENT 22 0.0003
819 LETHARGY 15 0.0003
820 WHITE BLOOD CELL COUNT INCREASED 10 0.0003
821 GYNAECOMASTIA 8 0.0003
822 ANKLE FRACTURE 4 0.0003
823 BLOOD GLUCOSE INCREASED 48 0.0003
824 BALANCE DISORDER 22 0.0003
825 CYANOSIS 4 0.0003
826 PRODUCT USE COMPLAINT 4 0.0003
827 PROCEDURAL PAIN 7 0.0003
828 HALLUCINATION, AUDITORY 4 0.0003
829 SYNCOPE 25 0.0002
830 NIGHT SWEATS 8 0.0002
831 FULL BLOOD COUNT DECREASED 5 0.0002
832 WRONG TECHNIQUE IN DRUG USAGE PROCESS 9 0.0002
833 PRESYNCOPE 6 0.0002
834 DEEP VEIN THROMBOSIS 16 0.0002
835 PRODUCT PREPARATION ERROR 5 0.0002
836 TOOTH LOSS 5 0.0002
837 APPLICATION SITE IRRITATION 3 0.0002
838 INJECTION SITE DISCOLOURATION 3 0.0002
839 NEPHROLITHIASIS 11 0.0002
840 MUSCULOSKELETAL STIFFNESS 21 0.0002
841 PSYCHOTIC DISORDER 7 0.0002
842 RENAL DISORDER 11 0.0002
843 ANAPHYLACTIC REACTION 13 0.0002
844 IMPAIRED WORK ABILITY 5 0.0002
845 ARTHROPATHY 13 0.0002
846 HAEMOGLOBIN DECREASED 24 0.0002
847 GENITAL HAEMORRHAGE 3 0.0002
848 DYSPHAGIA 22 0.0002
849 FAECES DISCOLOURED 5 0.0002
850 PRODUCT DISPENSING ERROR 5 0.0002
851 ANHEDONIA 6 0.0002
852 HYPERHIDROSIS 29 0.0002
853 EYE HAEMORRHAGE 3 0.0002
854 CHROMATURIA 5 0.0002
855 RASH PRURITIC 12 0.0002
856 PULMONARY EMBOLISM 21 0.0002
857 PALLOR 6 0.0002
858 APPLICATION SITE RASH 3 0.0002
859 MOVEMENT DISORDER 7 0.0002
860 RESPIRATORY ARREST 6 0.0002
861 HEPATIC STEATOSIS 4 0.0002
862 CARPAL TUNNEL SYNDROME 3 0.0002
863 HEPATIC CIRRHOSIS 4 0.0002
864 FRACTURE 4 0.0002
865 OCULAR HYPERAEMIA 10 0.0002
866 GASTRIC ULCER 4 0.0002
867 INTERNATIONAL NORMALISED RATIO INCREASED 6 0.0002
868 LIP SWELLING 7 0.0002
869 RASH ERYTHEMATOUS 10 0.0002
870 INJECTION SITE PRURITUS 14 0.0002
871 POST PROCEDURAL COMPLICATION 4 0.0002
872 TYPE 2 DIABETES MELLITUS 7 0.0002
873 PANCREATIC CARCINOMA 6 0.0002
874 ANOSMIA 3 0.0002
875 ENCEPHALOPATHY 5 0.0002
876 DEVICE USE ERROR 7 0.0002
877 INJECTION SITE BRUISING 16 0.0002
878 SEIZURE 23 0.0002
879 CONTRAINDICATED PRODUCT ADMINISTERED 6 0.0002
880 HAEMATEMESIS 5 0.0002
881 FLUSHING 20 0.0002
882 BODY TEMPERATURE INCREASED 4 0.0002
883 CEREBROVASCULAR ACCIDENT 33 0.0002
884 INFLAMMATION 10 0.0002
885 FEMUR FRACTURE 6 0.0002
886 INJECTION SITE ERYTHEMA 24 0.0002
887 DELUSION 3 0.0002
888 HAEMATOMA 5 0.0002
889 C-REACTIVE PROTEIN INCREASED 7 0.0002
890 UNDERDOSE 14 0.0002
891 ACCIDENTAL OVERDOSE 7 0.0002
892 ROAD TRAFFIC ACCIDENT 8 0.0002
893 KNEE ARTHROPLASTY 4 0.0002
894 ABSCESS 3 0.0002
895 BLOOD GLUCOSE DECREASED 9 0.0002
896 DYSARTHRIA 7 0.0002
897 JAUNDICE 5 0.0002
898 HYPOGLYCAEMIA 9 0.0002
899 PRODUCT PRESCRIBING ISSUE 4 0.0002
900 STAPHYLOCOCCAL INFECTION 6 0.0002
901 STOMATITIS 11 0.0002
902 INFUSION RELATED REACTION 12 0.0002
903 ANGIOEDEMA 8 0.0002
904 GAMMA-GLUTAMYLTRANSFERASE INCREASED 4 0.0002
905 DRUG ABUSE 15 0.0002
906 PLASMA CELL MYELOMA 7 0.0002
907 BLOOD UREA INCREASED 3 0.0002
908 RASH PAPULAR 4 0.0002
909 HEMIPARESIS 3 0.0002
910 TINNITUS 8 0.0002
911 MUSCLE TWITCHING 4 0.0002
912 DEVICE DEFECTIVE 3 0.0002
913 SURGERY 10 0.0002
914 LABORATORY TEST ABNORMAL 5 0.0002
915 DRUG ERUPTION 3 0.0002
916 GALLBLADDER DISORDER 3 0.0002
917 HYPOAESTHESIA 25 0.0002
918 IRRITABILITY 10 0.0002
919 DRUG EFFECT INCOMPLETE 6 0.0002
920 HYPERGLYCAEMIA 6 0.0002
921 FIBROMYALGIA 4 0.0002
922 CEREBRAL INFARCTION 4 0.0002
923 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 33 0.0002
924 LIMB DISCOMFORT 5 0.0002
925 DISEASE PROGRESSION 19 0.0002
926 BONE DENSITY DECREASED 5 0.0002
927 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 11 0.0002
928 SEDATION 4 0.0002
929 HAEMATOCRIT DECREASED 3 0.0002
930 ABORTION SPONTANEOUS 6 0.0001
931 RHEUMATOID ARTHRITIS 17 0.0001
932 COMPLETED SUICIDE 12 0.0001
933 HYPERKALAEMIA 5 0.0001
934 OSTEOARTHRITIS 6 0.0001
935 DRUG DOSE OMISSION BY DEVICE 11 0.0001
936 CONVULSION 8 0.0001
937 AGGRESSION 7 0.0001
938 CEREBRAL HAEMORRHAGE 5 0.0001
939 BREAST CANCER 13 0.0001
940 VAGINAL HAEMORRHAGE 6 0.0001
941 SEPTIC SHOCK 6 0.0001
942 LIVER FUNCTION TEST ABNORMAL 4 0.0001
943 NEEDLE ISSUE 4 0.0001
944 PRODUCT STORAGE ERROR 12 0.0001
945 PROSTATE CANCER 11 0.0001
946 ALOPECIA 26 0.0001
947 HEPATIC ENZYME INCREASED 9 0.0001
948 ACNE 10 0.0001
949 EMOTIONAL DISORDER 4 0.0001
950 COMA 6 0.0001
951 INJECTION SITE HAEMORRHAGE 10 0.0001
952 OVERDOSE 27 0.0001
953 METABOLIC ACIDOSIS 4 0.0001
954 HEPATIC CANCER 3 0.0001
955 INTENTIONAL OVERDOSE 8 0.0001
956 LIVER INJURY 3 0.0001
957 VISUAL ACUITY REDUCED 4 0.0001
958 EXPIRED PRODUCT ADMINISTERED 4 0.0001
959 GLYCOSYLATED HAEMOGLOBIN INCREASED 3 0.0001
960 ANAPHYLACTIC SHOCK 3 0.0001
961 NO ADVERSE EVENT 21 0.0001
962 JOINT STIFFNESS 3 0.0001
963 LYMPHADENOPATHY 4 0.0001
964 DRUG EFFECT DECREASED 6 0.0001
965 INJECTION SITE REACTION 7 0.0001
966 CARDIO-RESPIRATORY ARREST 4 0.0001
967 LACTIC ACIDOSIS 3 0.0001
968 EMOTIONAL DISTRESS 11 0.0001
969 LIVER DISORDER 4 0.0001
970 MATERNAL EXPOSURE DURING PREGNANCY 8 0.0001
971 PRODUCT SUBSTITUTION ISSUE 5 0.0001
972 COGNITIVE DISORDER 4 0.0001
973 DEVICE BREAKAGE 3 0.0001
974 DYSKINESIA 3 0.0001
975 BLINDNESS 3 0.0001
976 DEVICE LEAKAGE 3 0.0001
977 MALIGNANT NEOPLASM PROGRESSION 7 0.0001
978 ALANINE AMINOTRANSFERASE INCREASED 4 0.0001
979 BLOOD CREATININE INCREASED 4 0.0001
980 INJURY 4 0.0001
981 BRADYCARDIA 3 0.0001
982 PLATELET COUNT DECREASED 6 0.0001
983 THROMBOCYTOPENIA 6 0.0001
984 WHITE BLOOD CELL COUNT DECREASED 5 0.0000
985 TOXICITY TO VARIOUS AGENTS 7 0.0000
986 DRUG DEPENDENCE 6 0.0000
987 NEUTROPENIA 5 0.0000
988 DRUG WITHDRAWAL SYNDROME 3 0.0000